ClinicalTrials.Veeva

Menu

Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions

F

Fayoum University

Status

Completed

Conditions

Potentially Malignant Lesions
Oral Lichen Planus
Leukoplakia, Oral

Treatments

Diagnostic Test: Real-time Polymerase Chain Reaction technique

Study type

Observational

Funder types

Other

Identifiers

NCT05730855
1152014

Details and patient eligibility

About

The aim of this study is to evaluate salivary expression of lncRNA DQ786243 as a potential marker for diagnosis of oral potentially malignant lesions compared to normal controls and its effect on salivary expression of miRNA146a.

Enrollment

45 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • participants will be divided into 3 groups:

Group I: patients suffering from oral lichen planus Group II: patients suffering from leukoplakia Group III: healthy subjects who are systemically free, non-smokers, and not suffering from any oral mucosal lesions.

Exclusion criteria

  • Subjects taking any drugs inducing any changes that could affect the salivary flow.
  • Pregnant females.
  • Subjects have any allergies, infectious diseases or active dental abscesses during one month before saliva sampling.
  • Patients receiving any drugs related to the oral lesions in the past 6 month prior to sample collection.

Trial design

45 participants in 3 patient groups

Oral Lichen Planus
Treatment:
Diagnostic Test: Real-time Polymerase Chain Reaction technique
Leukoplakia
Treatment:
Diagnostic Test: Real-time Polymerase Chain Reaction technique
Healthy control
Treatment:
Diagnostic Test: Real-time Polymerase Chain Reaction technique

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems